Sigbal Trading Companion
Sigbal Trading Companion
Portfolio Alerts Watch List Cart Sign In
Categories
  • Indian Stocks
    • Electronics (1)
    • Finance (5)
    • Mutual Funds (79)
    • Stocks (5391)
    Show All Indian Stocks
  • Mutual Funds
    • Books (2)
    • Electronics (67)
    • Finance (1040)
    • Financial Services (3)
    • Jewelry (1)
    • View all (8) »
    Show All Mutual Funds
  • Decision Assistant
  • ST Ranking Table
  • MF Rank Table
  • Products meeting the search criteria

Search

B

Bedmutha Industries Ltd

Decent
Score 68/100  •  Decent
Bedmutha Industries Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health63/100
Valuation 80/100 · PB 1.564
Technical Avoid
1M -5.591% 6M -19.333% 1Y -39.286%
Confidence100%
Low leverage (D/E)Decent revenue growth
Weak ROEPromoter pledge present
View details
M

Mold-Tek Technologies Ltd

Decent
Score 68/100  •  Decent
Mold-Tek Technologies Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health78/100
Valuation 40/100 · PB 4.8832
Technical Watch
1M 10.306% 6M 43.924% 1Y -5.467%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
View details
I

Infollion Research Services Ltd

Decent
Score 68/100  •  Decent
Infollion Research Services Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health93/100
Valuation 20/100 · PB 7.0449
Technical Avoid
1M -11.111% 6M -17.368% 1Y -1.158%
Confidence100%
Low leverage (D/E)No promoter pledge
View details
P

Pavna Industries Ltd

Decent
Score 68/100  •  Decent
Pavna Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health68/100
Valuation 60/100 · PB 2.3947
Technical Avoid
1M 2.273% 6M 11.952% 1Y -42.013%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
View details
M

Medicamen Biotech Ltd

Decent
Score 68/100  •  Decent
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health62/100
Valuation 60/100 · PB 2.3959
Technical Avoid
1M 22.521% 6M -12.983% 1Y -29.818%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
View details
G

Grand Continent Hotels Ltd

Decent
Score 68/100  •  Decent
While Grand Continent Hotels Ltd shows potential in a recovering sector, inconsistencies in growth and profitability metrics warrant caution.
Company’s Health88/100
Valuation 40/100 · PB 4.3166
Technical Avoid
1M 0.415% 6M 20.172% 1Y 82.751%
Confidence100%
Low leverage (D/E)No promoter pledge
View details
B

Brooks Laboratories Ltd

Decent
Score 68/100  •  Decent
Brooks Laboratories Ltd shows potential in a growing sector, but faces challenges in growth consistency and profitability metrics.
Company’s Health55/100
Valuation 40/100 · PB 3.3306
Technical Avoid
1M -17.251% 6M -15.488% 1Y -20.332%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
View details
V

Valiant Laboratories Ltd

Decent
Score 68/100  •  Decent
Valiant Laboratories Ltd shows potential but faces challenges in profitability and growth drivers.
Company’s Health75/100
Valuation 80/100 · PB 1.9179
Technical Avoid
1M 0.072% 6M -11.436% 1Y -23.805%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
View details
V

Vision Infra Equipment Solutions Ltd

Decent
Score 68/100  •  Decent
While Vision Infra Equipment Solutions Ltd operates in a growing sector, its inconsistent financial performance and high valuation metrics suggest caution. The company has potential but faces significant execution risks.
Company’s Health84/100
Valuation 40/100 · PB 3.3471
Technical Watch
1M 6.33% 6M 59.388% 1Y 31.168%
Confidence100%
No promoter pledgeDecent revenue growth
High debt/equityThin margins
View details
A

Aditya BSL Nifty 50 ETF

Decent
Score 68/100  •  Decent
The Aditya BSL Nifty 50 ETF presents a decent investment opportunity with a stable outlook, driven by the performance of its underlying assets.
Company’s Health0/100
Valuation 0/100 · PB —
Technical Avoid
1M 0.069% 6M 5.911% 1Y -4.529%
Confidence80%
View details
K

Kriti Nutrients Ltd

Decent
Score 68/100  •  Decent
Kriti Nutrients Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health98/100
Valuation 60/100 · PB 2.1835
Technical Avoid
1M -7.596% 6M -10.012% 1Y -37.204%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
View details
J

Jenburkt Pharmaceuticals Ltd

Decent
Score 68/100  •  Decent
Jenburkt Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health84/100
Valuation 40/100 · PB 3.2705
Technical Watch
1M 4.281% 6M 23.817% 1Y 32.539%
Confidence100%
Low leverage (D/E)No promoter pledge
View details
S

Supreme Power Equipment Ltd

Decent
Score 68/100  •  Decent
While Supreme Power Equipment Ltd operates in a promising sector, its inconsistent growth and profitability metrics raise concerns. Caution is advised for potential investors.
Company’s Health95/100
Valuation 20/100 · PB 5.3703
Technical Avoid
1M 2.676% 6M 70.685% 1Y -9.123%
Confidence100%
Low leverage (D/E)No promoter pledge
View details
U

Ugar Sugar Works Ltd

Decent
Score 68/100  •  Decent
Ugar Sugar Works Ltd shows potential but faces challenges in growth consistency and profitability metrics. Investors should be cautious.
Company’s Health44/100
Valuation 60/100 · PB 2.2182
Technical Avoid
1M -0.416% 6M -0.699% 1Y -46.508%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEHigh debt/equity
View details
R

Rama Phosphates Ltd

Decent
Score 68/100  •  Decent
Rama Phosphates Ltd shows potential in a critical sector but faces challenges in growth consistency and valuation metrics.
Company’s Health53/100
Valuation 80/100 · PB 1.7547
Technical Watch
1M 22.294% 6M 70.546% 1Y 77.297%
Confidence100%
Low leverage (D/E)Decent revenue growth
Weak ROEPromoter pledge present
View details
  • |<
  • <
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • >
  • >|
Showing 3061 to 3075 of 10018 (668 Pages)
Information +
  • Cookie Policy
  • Legal Notice / Imprint
  • Risk Disclosure Statement
  • About Us
  • Privacy Policy
  • Terms & Conditions
Customer Service +
  • Contact Us
  • Returns
  • Site Map
Extras +
  • Android App
  • Gift Certificates
  • Affiliate
  • Specials
My Account +
  • My Account
  • Order History
  • Wish List
  • Newsletter

Sigbal Trading Companion © 2025